文献速递主动脉疾病

肾上固定与肾下固定腔内移植物肾脏并发症比较

Comparison of Renal Complications between Endografts with Suprarenal and Infrarenal Fixation.
PubMed 文献 · Eur J Vasc Endovasc Surg · 2017-03-06

基于NSQIP血管模块2011-2013年数据,比较肾上固定(Zenith、Endurant)与肾下固定(Excluder)EVAR的30天结局。肾上固定组肾脏并发症(1.1% vs 0.1%)和住院超过2天(34% vs 25%)更常见,校正后肾上固定与肾脏并发症风险显著升高相关(OR 12.0,95%CI 1.6-91)。

要点

  • 肾上固定EVAR肾脏并发症发生率高于肾下固定(1.1% vs 0.1%)。
  • 校正后肾上固定肾脏并发症风险显著升高(OR 12.0,95%CI 1.6-91)。
  • 肾上固定组住院超过2天比例更高(34% vs 25%)。

核心结论

  • EVAR后肾脏并发症总体发生率低,但肾上固定支架移植物患者肾脏并发症和住院时间延长风险增加。

研究设计与样本

  • 利用NSQIP Targeted Vascular Module识别2011至2013年因肾下腹主动脉瘤行EVAR的患者,比较肾上固定(Zenith和Endurant)与肾下固定(Excluder)的术前、术中变量及30天结局,共纳入3587例患者。

主要发现

  • 肾上固定组2273例(63%),肾下固定组1314例(37%)。
  • 肾上固定组肾脏并发症发生率为1.1%,肾下固定组为0.1%(p < .01)。
  • 肾上固定组住院超过2天发生率为34%,肾下固定组为25%(p < .01)。
  • 多因素回归校正后,肾上固定与肾脏并发症风险升高相关(OR 12.0;95%CI 1.6-91),并与住院超过2天相关(OR 1.4;95%CI 1.2-1.7)。

关键数值与推荐

  • 肾脏并发症定义为NSQIP标准下的肌酐升高> 2 mg/dL或新发透析。

临床怎么用

  • 选择肾上固定EVAR时需权衡肾脏并发症风险,术后应关注肾功能和住院时间。

局限性

  • 肾上固定组肾脏并发症风险升高可能源于选择偏倚、释放技术或裸支架覆盖肾动脉,需进一步研究机制和长期结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Surgeons have multiple grafts options available for the endovascular treatment of abdominal aortic aneurysm (EVAR), and some hypothesize that suprarenal fixation endografts may result in higher rates of renal complications than infrarenal endografts. This study aimed to compare the outcomes of contemporary suprarenal and infrarenal endografts. METHODS: The Targeted Vascular Module of the National Surgical Quality Improvement Project was utilised to identify patients undergoing EVAR for infrarenal aneurysm from 2011 to 2013. Pre-operative and operative variables and 30 day outcomes were compared among suprarenal (Zenith and Endurant) and infrarenal fixation devices (Excluder). Renal complications included creatinine increase > 2 mg/dL or new dialysis, as defined by NSQIP. Multivariate regression was completed to account for patient demographics, comorbidities, and operative characteristics. RESULTS: A total of 3587 patients were evaluated including 2273 (63%) with suprarenal grafts and 1314 (37%) with infrarenal grafts. Patients with suprarenal grafts were less commonly white (84% vs. 88%, p < .01) and more commonly male (83% vs. 80%, p = .03). There were no differences in age or comorbidities. Renal complications (1.1% vs. 0.1%, p < .01) and length of stay more than 2 days (34% vs. 25%, p < .01) occurred more commonly after suprarenal fixation. After adjustment, suprarenal grafts had significantly higher rates of renal complications (OR, 12.0; 95% CI, 1.6-91) and length of stay more than 2 days (OR, 1.4; 95% CI, 1.2-1.7). CONCLUSION: Overall rates of renal complications following EVAR are low. Patients selected for suprarenal stent grafts are at increased risk of renal complications and prolonged length of stay, which may be due to selection bias, deployment techniques, or the presence of a bare stent overlying the renal arteries. Further studies are necessary to evaluate the mechanism and duration of renal dysfunction and important long-term outcomes of interest.

来源:Eur J Vasc Endovasc Surg,查看原文。版权归原作者所有。

引用

  1. Zettervall SL, Soden PA, Deery SE, et al. Comparison of Renal Complications between Endografts with Suprarenal and Infrarenal Fixation. Eur J Vasc Endovasc Surg. 2017. PMID: 28279653. doi:10.1016/j.ejvs.2017.02.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。